Literature DB >> 2900920

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

J S Yudkin1, R D Forrest, C A Jackson.   

Abstract

The relation between urinary albumin excretion rate (AER) and vascular disease was studied in 187 subjects aged over 40 selected from 1084 cases attending a diabetic screening project. AER exceeded 20 micrograms/min in 3 of 13 newly diagnosed diabetic subjects (23%) and 16 of 171 non-diabetic subjects (9.4%). There was a weak relation between AER and both systolic and diastolic blood pressures. Coronary heart disease was found in 54 of 164 (32.9%) subjects with AER of 20 micrograms/min or less and in 14 of 19 (74%) with AER above this. Peripheral vascular disease was present in 16 of 165 (9.7%) subjects with AER of 20 micrograms/min or less and 8 of 18 (44%) with a high AER. Logistic regression, including diabetes, impaired glucose tolerance, systolic and diastolic blood pressures, smoking, age, sex, ethnic origin, and body mass index, demonstrated the independence of this relation between AER above 20 micrograms/min and coronary heart disease (odds ratio [OR] 6.38, 95% confidence interval 1.91-21.4) and peripheral vascular disease (OR 7.72, 2.14-27.8). After a mean of 3.6 (SD 0.19) years, 167 subjects (89.3%) were traced. There had been 9 deaths, 3 (2.0%) among 149 subjects with normal AER and 6 (33%) among 18 microalbuminuric subjects (OR 24.33, 5.40-109.7).

Entities:  

Mesh:

Year:  1988        PMID: 2900920     DOI: 10.1016/s0140-6736(88)92657-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  116 in total

1.  The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.

Authors:  Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

2.  Diagnosis of an ectopic ureter in a girl by differential urine collection after administration of desmopressin acetate.

Authors:  A Thimm; M G Coulthard
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

Review 3.  Microalbuminuria and diabetic cardiovascular disease.

Authors:  Richard J MacIsaac; Mark E Cooper
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

4.  A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.

Authors:  O Samuelsson; T Hedner; S Ljungman; H Herlitz; B Widgren; K Pennert
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Microalbuminuria.

Authors:  P H Winocour
Journal:  BMJ       Date:  1992-05-09

Review 6.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 7.  Drugs for cardiovascular risk reduction in the diabetic patient.

Authors:  D S Bell
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

8.  Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria.

Authors:  Goh Eun Chung; Nam Ju Heo; Min Jung Park; Su Jin Chung; Hae Yeon Kang; Seung Joo Kang
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM.

Authors:  J H Pinkney; W J Foyle; A E Denver; V Mohamed-Ali; S McKinlay; J S Yudkin
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.